Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2006 Jun;61(6):546; author reply 546.

RSV infection in prematurely born infants

Comment

RSV infection in prematurely born infants

S Deshpande. Thorax. 2006 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The author has previously questioned the cost effectiveness of palivizumab in relation to its recommended indications.

Comment on

References

    1. Broughton S, Roberts A, Fox G.et al Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants. Thorax 2005601039–1044. - PMC - PubMed
    1. Manktelow B N, Draper E S, Annamalai S.et al Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997. Arch Dis Child Fetal Neonatal Ed 200185F33–F35. - PMC - PubMed
    1. Smith V C, Zupancic J A, McCormick M C.et al Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr 2005146469–473. - PubMed
    1. Broughton S, Bhat R, Roberts A.et al Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants. Arch Dis Child 20069126–30. - PMC - PubMed
    1. IMpact‐RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high‐risk infants. Pediatrics 1998102531–537. - PubMed

MeSH terms